Stryker Neptune Recall Issued for Waste Drainage Devices

A class 1 recall has been issued for Stryker’s Neptune Waste Management Systems following reports involving a number of serious injuries in connection with the devices, including at least one death. 

An expanded Stryker Neptune Rover Waste Management System recall was issued on September 25, following an initial recall notice issued on June 5 for a limited number of the devices.

The FDA has determined that the action qualifies as a class 1 recall, which is the most serious type of medical device recall, after the agency notified the manufacturer that it has determined the products can not be established as safe or effective. The recall affects devices sold in the United States, Asia Pacific, Canada, Japan, Latin America and Europe.

Did You Know? Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

The initial recall impacted the Neptune 2 Rover, with Stryker warning clients against connecting the device to passive drainage tubes, after reports were received involving injury to users resulting in tissue damage and one fatality when the device was connected to a passive chest drainage tube post operative.

Stryker has now expanded the recall to include Neptune 1 Silver, Neptune 2 Ultra (120V), Neptune and 2 Ultra (320V) after the FDA notified the company that it was unauthorized for 510(k) clearance due to safety and effectiveness concerns. The FDA has advised consumers not to use these waste systems.

The series of Neptune Waste Management Systems are high vacuum/high flow devices used in operating rooms during surgeries to collect surgical waste. They are designed to collect the waste and dispose of the fluids without exposing healthcare workers.

Stryker also notified customers that it is recalling the instructions for use, as the initial label did not include the specific instructions included in the June 5 recall, which recommends against connecting the devices to passive drainage tubes. The lack of this specific warning has been linked to the one reported Neptune fatality.

Stryker notified its clients that they are required to submit a certificate of medical necessity and return it to the company by Oct. 12 if they choose to continue using the devices. The company also advised clients to weigh the risks and benefits of continued use carefully if there is no alternative device available.

Clients who continue use and submit the certificate of medical necessity will then receive followup safety details and instructions on proper use of the devices. The company has stopped distribution of the devices pending FDA approval.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Direct Filing of NEC Lawsuits Against Similac, Enfamil Manufacturers To Be Permitted in MDL
Direct Filing of NEC Lawsuits Against Similac, Enfamil Manufacturers To Be Permitted in MDL (Posted 5 days ago)

A federal judge plans to approve direct filing of future NEC lawsuits straight to the MDL court, streamlining the process for parents pursuing claims against the makers of Similac and Enfamil cow's milk-based formula.